Announcements

Financial Year 2025-26

Financial Year 2024-25

Financial Year 2023-24

Financial Year 2025-26

Financial Year 2024-25

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation Of Material Event-High Court Jharkhand Order Civil Litigation Related To Cancer Hospital Land
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Notice of 1st / 25-26 Board Meeting
Closure of Trading Window
Reconciliation of Share Capital Audit Report under Regulation 76 of SEBI 31122024
Structured Digital Database Certificate 3rd QTR
Closure of Trading Window 01/01/2025
Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer' Of The Company Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Intimation Of Material Event - Possession & Registry Of Land.
Outcome Of Board Meeting Held On 30Th October, 2024 And Submission Of Unaudited Financial Results For The Half Year Ended 30Th September, 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue
Announcement Regarding Expansion Of Services Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) 2015.
Announcement Regarding Grant Of Approval From Pharmacy Council Of India For D. Pharm Course Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Closure of Trading Window
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Intimation Regarding Revision In Credit Rating.
Additional Disclosure As Required Under Regulation 30 Of SEBI (LODR) Regulations,2015.
Reg. 34 (1) Annual Report.
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) 2015.
Disclosure Of The Impact Of Audit Qualifications On Asarfi Hospital Limited Standalone & Consolidated Financial Statements.
Announcement Under Regulation 30 Of LODR Regulation, 2015 Regarding Board Comment On SDD Non-Compliance
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024
IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024
Intimation Relating To Disposal Of Appeal Filed (Civil Appeal 6781-6782 / 2023) In Hon'Ble Supreme Court Of India In Favour Of Asarfi Hospital Limited Filed Against The Order Of The Hon'Ble High Court In FA 43 Of 2012 Relating To Land Allotted By State Of Jharkhand For Establishment Of Cancer Hospital.
Audited Results For 31.03.2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May 2024 And Submission Of Unaudited Financial Results For The Half Year And Year Ended 31St March 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Board Meeting Intimation for Adopting The Unaudited Financial Results For The Half Year And Year Ending 31 March 2024.
Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliances-Reg.24(A)-Annual Secretarial Compliance
Closure of Trading Window
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Financial Year 2023-24

Asarfi Hospital Limited has signed a Memorandum of Undersatanding ( MoU) with Gleneagles Hospital, Chennai, to set up Jharkhand''s first Multi Organ Transplant Unit at our hospital in Dhanbad.

Financial Year 2025-26

Investors